Global burden of COVID-19: Situational analyis and review.

Q3 Medicine Human Antibodies Pub Date : 2021-01-01 DOI:10.3233/HAB-200420
Addis Adera Gebru, Tadesse Birhanu, Eshetu Wendimu, Agumas Fentahun Ayalew, Selamawit Mulat, Hussen Zakir Abasimel, Ali Kazemi, Bosenu Abera Tadesse, Beniam Adera Gebru, Berhanu Senbeta Deriba, Nigus Shimelis Zeleke, Abebe Gule Girma, Bulgantsetseg Munkhbat, Qamar Kassim Yusuf, Amana Ogeto Luke, Dejene Hailu
{"title":"Global burden of COVID-19: Situational analyis and review.","authors":"Addis Adera Gebru,&nbsp;Tadesse Birhanu,&nbsp;Eshetu Wendimu,&nbsp;Agumas Fentahun Ayalew,&nbsp;Selamawit Mulat,&nbsp;Hussen Zakir Abasimel,&nbsp;Ali Kazemi,&nbsp;Bosenu Abera Tadesse,&nbsp;Beniam Adera Gebru,&nbsp;Berhanu Senbeta Deriba,&nbsp;Nigus Shimelis Zeleke,&nbsp;Abebe Gule Girma,&nbsp;Bulgantsetseg Munkhbat,&nbsp;Qamar Kassim Yusuf,&nbsp;Amana Ogeto Luke,&nbsp;Dejene Hailu","doi":"10.3233/HAB-200420","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The novel Coronavirus Disease 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of the global community due to this disease is dramatically increasing from time to time.</p><p><strong>Objective: </strong>This situational analysis is aimed to analyse prevalence and incidence of COVID-19 and to provide clear information about this disease for the scientific community, stakeholders, healthcare practitioners and decision-makers.</p><p><strong>Methods: </strong>The literatures were identified by searching the key relevant and officially known online databases: medRxiv, Google scholar and PubMed. The online databases contain archives of most English biomedical journals and scientific papers published online from 31 December to 3 April 2020 were included. After the literature search, articles were screened independently by two reviewers for eligibility.</p><p><strong>Results: </strong>The world continents have confirmed a total of 1,202,320 confirmed COVID-19 cases: (51.2%) in Europe, (27.7%) in North America, (17.9%) in Asia, (1.96%) in South America and at less number of confirmed COVID-19 cases in Africa and Australia which was accounted 0.8% and 0.5%, respectively. However, this review showed that there was a significant increase in the confirmed COVID-19 cases by 109,555 in Asia, 8,658 in Africa, 332,866 in North America, 20,269 in South America, 568,894 in Europe, 5,051 in Australia and 1,045,403 in the whole world, with the exception of Antartica, during the review period. The overall results showed that there were 1,098,762 cases and 59,172 deaths recorded during the review period. The result zero number of deaths with COVID-19 was observed in 66 countries.</p><p><strong>Conclusion: </strong>The review concluded that COVID-19; SARS-CoV-2 is the major public health burden in the world, the morbidity and mortality of global community is dramatically increasing from time to time. Strong collaboration among all sectors and the design of effective prevention and control strategies which include staying home, social/physical distancing, quarantine, testing of suspected patients, isolation and managing of the confirmed cases. Therefore, all countries should implement five major COVID-19 prevention and control programmes as soon as possible at community level.</p>","PeriodicalId":53564,"journal":{"name":"Human Antibodies","volume":"29 2","pages":"139-148"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/HAB-200420","citationCount":"28","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Antibodies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/HAB-200420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 28

Abstract

Background: The novel Coronavirus Disease 2019 (COVID-19) is the major public health burden in the world. The morbidity and mortality of the global community due to this disease is dramatically increasing from time to time.

Objective: This situational analysis is aimed to analyse prevalence and incidence of COVID-19 and to provide clear information about this disease for the scientific community, stakeholders, healthcare practitioners and decision-makers.

Methods: The literatures were identified by searching the key relevant and officially known online databases: medRxiv, Google scholar and PubMed. The online databases contain archives of most English biomedical journals and scientific papers published online from 31 December to 3 April 2020 were included. After the literature search, articles were screened independently by two reviewers for eligibility.

Results: The world continents have confirmed a total of 1,202,320 confirmed COVID-19 cases: (51.2%) in Europe, (27.7%) in North America, (17.9%) in Asia, (1.96%) in South America and at less number of confirmed COVID-19 cases in Africa and Australia which was accounted 0.8% and 0.5%, respectively. However, this review showed that there was a significant increase in the confirmed COVID-19 cases by 109,555 in Asia, 8,658 in Africa, 332,866 in North America, 20,269 in South America, 568,894 in Europe, 5,051 in Australia and 1,045,403 in the whole world, with the exception of Antartica, during the review period. The overall results showed that there were 1,098,762 cases and 59,172 deaths recorded during the review period. The result zero number of deaths with COVID-19 was observed in 66 countries.

Conclusion: The review concluded that COVID-19; SARS-CoV-2 is the major public health burden in the world, the morbidity and mortality of global community is dramatically increasing from time to time. Strong collaboration among all sectors and the design of effective prevention and control strategies which include staying home, social/physical distancing, quarantine, testing of suspected patients, isolation and managing of the confirmed cases. Therefore, all countries should implement five major COVID-19 prevention and control programmes as soon as possible at community level.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19全球负担:情况分析和审查。
背景:2019年新型冠状病毒病(COVID-19)是全球主要的公共卫生负担。由于这种疾病,全球社会的发病率和死亡率不时急剧增加。目的:本情景分析旨在分析COVID-19的流行和发病率,为科学界、利益相关者、卫生保健从业人员和决策者提供明确的疫情信息。方法:通过检索medRxiv、Google scholar和PubMed等官方知名的关键在线数据库进行文献检索。在线数据库包含了从12月31日至2020年4月3日在线发表的大多数英语生物医学期刊和科学论文的档案。文献检索后,文章由两位审稿人独立筛选。结果:全球各大洲累计确诊病例1202320例,其中欧洲(51.2%)、北美(27.7%)、亚洲(17.9%)、南美(1.96%),非洲和澳大利亚确诊病例较少,分别占0.8%和0.5%。但是,本次审查结果显示,在审查期间,亚洲新增确诊病例109555例,非洲新增确诊病例8658例,北美新增确诊病例332866例,南美新增确诊病例20269例,欧洲新增确诊病例568894例,澳大利亚新增确诊病例5051例,除南极洲外,全球新增确诊病例1045403例。总体结果表明,在审查期间记录了1 098 762例病例和59 172例死亡。结果,66个国家的COVID-19死亡人数为零。结论:综述结论:COVID-19;SARS-CoV-2是世界上主要的公共卫生负担,全球发病率和死亡率不时急剧上升。所有部门之间的密切合作,并制定有效的预防和控制战略,包括呆在家里、保持社交/身体距离、隔离、检测疑似患者、隔离和管理确诊病例。因此,各国应尽快在社区层面实施五大疫情防控规划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Human Antibodies
Human Antibodies Medicine-Immunology and Allergy
CiteScore
3.50
自引率
0.00%
发文量
27
期刊介绍: Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.
期刊最新文献
Assessment of CD40L and TSAB serum level in Graves disease patients. Development and characterization of three novel mouse monoclonal antibodies targeting spike protein S1 subunit of Middle East Respiratory Syndrome Corona Virus. The role of vitamin D against COVID-19 infection, progression and severity. The rebirth of epitope-based patent claims. Effect of physical exercise on inactivated COVID-19 vaccine antibody response in the elderly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1